Bristol-Myers Squibb / AstraZeneca Satellite Symposium - The 2nd Latin America Congress on Controversies to Consensus to Diabetes, Obesity and Hypertension (CODHy)

The 2nd Latin America Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Rio de Janeiro, Brazil, March 22-25, 2012

Bristol-Myers Squibb / AstraZeneca Satellite Symposium

This educational programme is accredited by the Royal College of Physicians of the United Kingdom for 2 credits

Friday, March 23, 2012
17:00-19:00

SGLT2 inhibition and the ‘CODHy’ controversies: glycaemic control and beyond
17:00-17:30	Light refreshments
17:30-17:45	Welcome and introduction Antonio R. Chacra, Chair São Paulo, Brazil
17:45-18:10	The challenges of managing vascular risk in T2DM A. Enrique Caballero Boston, USA
18:10-18:35	SGLT2 inhibitors: a new approach to treatment in T2DM? Artur B. Ribeiro São Paulo, Brazil
18:35-19:00	SGLT2 inhibitors: clinical experience John Wilding Liverpool, UK